Cenobamate

FDA APPROVAL DATE: 11/21/2019

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Carbamazepine, Clobazam, CYP2B6 substrates, CYP3A substrates, CYP2C19 substrates, Lamotrigine, Oral Contraceptives, Phenobarbital, Phenytoin


Based on animal data, may cause fetal harm. Women of reproductive potential concomitantly using oral contraceptives should use additional or alternative non-hormonal birth control.

Often used as an adjunctive therapy with other anticonvulsant (antiseizure) medication.

Our database has 49 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 05/14/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top